Literature DB >> 8337603

Cytokines and alcoholic liver disease.

C McClain1, D Hill, J Schmidt, A M Diehl.   

Abstract

It is clear that cytokines cause metabolic disturbances that are similar to known complications of AH. TNF appears to be a proximal mediator of multiple types of experimental liver injury and TNF activity is elevated in ALD, as are the levels of certain other cytokines. On the other hand, low physiologic amounts of cytokines appear to be important for liver regeneration (and perhaps are beneficial to the organism as a whole). Goals for evaluation of anticytokine therapy in ALD will be: (1) determining the timing and type of the particular anticytokine employed (such as, immediate administration of antibody followed by an inhibitor of cytokine production), (2) appropriate monitoring of drug effects on cytokine metabolism as well as liver function and outcome, and (3) maintenance of the regenerative or positive physiologic effects of cytokines while blocking the cytolytic effects. Thus, we predict that ultimate anticytokine therapy will be directed at conserving the positive growth-enhancing effects of cytokines while attenuating their cytolytic effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8337603     DOI: 10.1055/s-2007-1007347

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  34 in total

Review 1.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography.

Authors:  H R Rosen; P J Winkle; B J Kendall; D L Diehl
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

4.  Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

Authors:  Wei Cui; Stephen L Chen; Ke-Qin Hu
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 5.  The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease.

Authors:  Danielle Y F Twum; Lauren Burkard-Mandel; Scott I Abrams
Journal:  J Leukoc Biol       Date:  2017-02-13       Impact factor: 4.962

6.  Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.

Authors:  N C Fisher; D A Neil; A Williams; D H Adams
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

7.  Abrogation of nuclear factor-kappaB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha production and liver injury.

Authors:  Zhanxiang Zhou; Lipeng Wang; Zhenyuan Song; Jack T Saari; Craig J McClain; Y James Kang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 8.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

Review 9.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

10.  Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease.

Authors:  Leila Gobejishvili; Shirish Barve; Swati Joshi-Barve; Craig McClain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-07       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.